5 Questions with Jennifer Butler, Executive Vice President and General Manager of Innate Pharma U.S. “5 Questions With……” is a new BioBuzz series where we reach out to interesting people [….]
5 Questions with Byung Ha Lee, Director, R&D at NeoImmuneTech, Inc. “5 Questions With……” is a new BioBuzz series where we reach out to interesting people in the BioHealth Capital [….]
5 Questions With John Trainer, CFO, NexImmune, Inc. “5 Questions With……” is a new BioBuzz series where we reach out to interesting people in the BioHealth Capital Region to share [….]
NexImmune Bolsters Leadership Team Adding Former MedImmune Executive as Chief Financial Officer GAITHERSBURG, Md., Jan. 09, 2020 (Excerpts below were originally published on GLOBE NEWSWIRE) NexImmune, a clinical-stage biopharmaceutical company [….]
NexImmune Appoints Industry Veteran Chief Medical Officer to Executive Team GAITHERSBURG, Md., Jan. 09, 2020 (originally published on GLOBE NEWSWIRE) NexImmune, a clinical-stage biopharmaceutical company developing novel immune-therapeutics based on [….]
BioHealth Capital Region Startups Raised More Than $739M in 2019 These 15 Biohealth Startups had a Banner Year, Setting Themselves Up for Success in 2020 The startup ecosystem in the [….]
Emerging T Cell Therapy Company NexImmune Receives First IND Clearance for Phase 1/2 Trial in Acute Myeloid Leukemia / Myelodysplastic Syndrome October 31, 2019 07:30 ET | Source: NexImmune, Inc. IND clearance enables [….]
Serial Entrepreneurs of the Biohealth Capital Region A strong group of entrepreneurs ready and willing to innovate, fund and lead new bioscience companies is essential to the creation and sustainability [….]
